Characterization of novel transforming growth factor-beta type I receptors found in malignant pleural effusion tumor cells

BMC Molecular Biology

Volumn 8, Issue , 2007, Pages

  Chen, Kuo Li ^a   Liu, Wan Hsin ^b   Yang, Yi Yuan ^c   Leu, Sy Jye C ^c   Shih, Neng Yao ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYCLOHEXIMIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; ISOPROTEIN; PROTEIN SERINE THREONINE KINASE; RNA; SIGNAL PEPTIDE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONTROLLED STUDY; GENE DELETION; GENETIC VARIABILITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULAR CLONING; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PLEURA EFFUSION; PROTEIN EXPRESSION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CELL PROLIFERATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MOLECULAR SEQUENCE DATA; PLEURAL EFFUSION, MALIGNANT; PROTEIN ISOFORMS; PROTEIN SORTING SIGNALS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, NEOPLASM;

EID: 34848822904     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-8-72     Document Type: Article

References (40)

1. Ceyhan BB Demiralp E Karakurt ZL Karakurt S Sungur M Transforming growth factor beta-1 level in pleural effusion Respirology 2003 8 3 321-325 10.1046/j.1440-1843.2003.00474.x 12911825
2. Moustakas A Lin HY Henis YI Plamondon J O'Connor-McCourt MD Lodish HF The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand J Biol Chem 1993 268 30 22215-22218 7693660
3. Blobe GC Schiemann WP Lodish HF Role of transforming growth factor beta in human disease N Engl J Med 2000 342 18 1350-1358 10.1056/ NEJM200005043421807 10793168
4. Pasche B Kaklamani V Hou N Young T Rademaker A Peterlongo P Ellis N Offit K Caldes T Reiss M Zheng T TGFBR1*6A and cancer: A meta-analysis of 12 case-control studies J Clin Oncol 2004 22 4 756-758 10.1200/JCO.2004.99.271 14966109
5. Pasche B Kolachana P Nafa K Satagopan J Chen YG Lo RS Brener D Yang D Kirstein L Oddoux C Ostrer H Vineis P Varesco L Jhanwar S Luzzatto L Massague J Offit K TbetaR-I(6A) is a candidate tumor susceptibility allele Cancer Res 1999 59 22 5678-5682 10582683
6. Derynck R Akhurst RJ Balmain A TGF-beta signaling in tumor suppression and cancer progression Nat Genet 2001 29 2 117-129 10.1038/ng1001-117 11586292
7. Baxter SW Choong DY Eccles DM Campbell IG Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer Cancer Epidemiol Biomarkers Prev 2002 11 2 211-214 11867510
8. Chen T Triplett J Dehner B Hurst B Colligan B Pemberton J Graff JR Carter JH Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas Cancer Res 2001 61 12 4679-4682 11406536
9. Wang D Kanuma T Mizunuma H Takama F Ibuki Y Wake N Mogi A Shitara Y Takenoshita S Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer Cancer Res 2000 60 16 4507-4512 10969799
10. Choi ME Cloning and characterization of a naturally occurring soluble form of TGF-beta type I receptor Am J Physiol 1999 276 1 Pt 2 F88-95 9887084
11. Zhang HT Zhao J Zheng SY Chen XF Is TGFBR1*6A really associated with increased risk of cancer? J Clin Oncol 2005 23 30 7743 4; author reply 7744-6. 10.1200/JCO.2005.02.9108 16234535
12. Chen T de Vries EG Hollema H Yegen HA Vellucci VF Strickler HD Hildesheim A Reiss M Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma Int J Cancer 1999 82 1 43-51 10.1002/ (SICI)1097-0215(19990702)82:1<43::AID-IJC9>3.0.CO;2-0 10360819
13. Pasche B Knobloch TJ Bian Y Liu J Phukan S Rosman D Kaklamani V Baddi L Siddiqui FS Frankel W Prior TW Schuller DE Agrawal A Lang J Dolan ME Vokes EE Lane WS Huang CC Caldes T Di Cristofano A Hampel H Nilsson I von Heijne G Fodde R Murty VV de la Chapelle A Weghorst CM Somatic acquisition and signaling of TGFBR1*6A in cancer JAMA 2005 294 13 1634-1646 10.1001/jama.294.13.1634 16204663
14. Schiemann WP Rotzer D Pfeifer WM Levi E Rai KR Knaus P Kadin ME Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor Cancer Detect Prev 2004 28 1 57-64 10.1016/j.cdp.2003.11.001 15041079
15. Feng XH Derynck R Specificity and versatility in tgf-beta signaling through Smads Annu Rev Cell Dev Biol 2005 21 659-693 10.1146/ annurev.cellbio.21.022404.142018 16212511
16. Derynck R Zhang YE Smad-dependent and Smad-independent pathways in TGF-beta family signalling Nature 2003 425 6958 577-584 10.1038/ nature02006 14534577
17. Spillman MA Schildkraut JM Halabi S Moorman P Calingaert B Bentley RC Marks JR Murphy S Berchuck A Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk Gynecol Oncol 2005 97 2 543-549 10.1016/j.ygyno.2005.01.025 15863158
18. Samowitz WS Curtin K Leppert MF Slattery ML Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer Genes Chromosomes Cancer 2001 32 4 381-383 10.1002/gcc.1203 11746979
19. Suarez BK Pal P Jin CH Kaushal R Sun G Jin L Pasche B Deka R Catalona WJ TGFBR1*6A is not associated with prostate cancer in men of European ancestry Prostate Cancer Prostatic Dis 2005 8 1 50-53 10.1038/ sj.pcan.4500765 15505640
20. Zhang HT Fei QY Chen F Qi QY Zou W Wang JC Zhang RM Tao SH Chen XF Luo ZW Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer Lung Cancer 2003 40 3 281-287 12781426
21. Maas S Patt S Schrey M Rich A Underediting of glutamate receptor GluR-B mRNA in malignant gliomas Proc Natl Acad Sci U S A 2001 98 25 14687-92. Epub 2001 Nov 20. 64742 11717408 10.1073/pnas.251531398
22. Beghini A Ripamonti CB Peterlongo P Roversi G Cairoli R Morra E Larizza L RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia Hum Mol Genet 2000 9 15 2297-2304 11001933
23. Sharma PM Bowman M Madden SL Rauscher FJ 3rd Sukumar S RNA editing in the Wilms' tumor susceptibility gene, WT1 Genes Dev 1994 8 6 720-731 10.1101/gad.8.6.720 7926762
24. Maas S Rich A Changing genetic information through RNA editing Bioessays 2000 22 9 790-802 10.1002/ 1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0 10944581
25. Vellucci VF Reiss M Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene Genomics 1997 46 2 278-283 10.1006/geno.1997.5023 9417915
26. Whiteside ST Ernst MK LeBail O Laurent-Winter C Rice N Israel A N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity Mol Cell Biol 1995 15 10 5339-5345 230782 7565683
27. Ishida N Tanaka K Tamura T Nishizawa M Okazaki K Sagata N Ichihara A Mos is degraded by the 26S proteasome in a ubiquitin-dependent fashion FEBS Lett 1993 324 3 345-348 10.1016/0014-5793(93)80148-N 8405379
28. Bachmair A Varshavsky A The degradation signal in a short-lived protein Cell 1989 56 6 1019-1032 10.1016/0092-8674(89)90635-1 2538246
29. Varshavsky A The N-end rule: Functions, mysteries, uses Proc Natl Acad Sci U S A 1996 93 22 12142-12149 37957 8901547 10.1073/pnas.93.22.12142
30. Graciet E Hu RG Piatkov K Rhee JH Schwarz EM Varshavsky A Aminoacyl-transferases and the N-end rule pathway of prokaryotic/ eukaryotic specificity in a human pathogen Proc Natl Acad Sci U S A 2006 103 9 3078-83. Epub 2006 Feb 21. 1413915 16492767 10.1073/pnas.0511224103
31. Orlowski M Wilk S Ubiquitin-independent proteolytic functions of the proteasome Arch Biochem Biophys 2003 415 1 1-5 10.1016/ S0003-9861(03)00197-8 12801506
32. Nielsen H Engelbrecht J Brunak S von Heijne G Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites Protein Eng 1997 10 1 1-6 10.1093/protein/10.1.1 9051728
33. Saitoh M Nishitoh H Amagasa T Miyazono K Takagi M Ichijo H Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta J Biol Chem 1996 271 5 2769-2775 10.1074/ jbc.271.5.2769 8576253
34. Feng XH Derynck R A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity EMBO J 1997 16 13 3912-3923 1170015 9233801 10.1093/emboj/16.13.3912
35. DeCoteau JF Knaus PI Yankelev H Reis MD Lowsky R Lodish HF Kadin ME Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 1997 94 11 5877-5881 20874 9159168 10.1073/pnas.94.11.5877
36. Kim IY Ahn HJ Zelner DJ Shaw JW Lang S Kato M Oefelein MG Miyazono K Nemeth JA Kozlowski JM Lee C Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues Clin Cancer Res 1996 2 8 1255-1261 9816295
37. Masuda N Fukuoka M Takada M Kudoh S Kusunoki Y Establishment and characterization of 20 human non-small cell lung cancer cell lines in a serum-free defined medium (ACL-4) Chest 1991 100 2 429-438 1650680
38. Chen YM Tsai CM Whang-Peng J Perng RP Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes Chest 2002 122 4 1421-1427 10.1378/ chest.122.4.1421 12377874
39. Imai Y Matsushima Y Sugimura T Terada M A simple and rapid method for generating a deletion by PCR Nucleic Acids Res 1991 19 10 2785 328208 1645866 10.1093/nar/19.10.2785
40. Shih NY Li J Karpitskii V Nguyen A Dustin ML Kanagawa O Miner JH Shaw AS Congenital nephrotic syndrome in mice lacking CD2-associated protein Science 1999 286 5438 312-315 10.1126/science.286.5438.312 10514378